Is it typical to get an NT‑proBNP (N‑terminal pro‑B‑type natriuretic peptide) result reported as < 36 pg/mL, and what clinical significance differentiates a value near zero from one near 35 pg/mL? Does this distinction add any useful information?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NT-proBNP Values <36 pg/mL: Clinical Significance and Interpretation

When NT-proBNP is reported as <36 pg/mL (below the assay's lower detection limit), this effectively rules out heart failure and ventricular dysfunction with extremely high confidence, and the distinction between a value near zero versus near 35 pg/mL provides no clinically meaningful additional information.

Why Values <36 pg/mL Are Reported This Way

Modern NT-proBNP assays have a limit of detection (LoD) typically between 4.8-5 ng/L (approximately 5 pg/mL) 1, but laboratories often report results as "<36 pg/mL" when values fall below their validated lower limit of quantitation (LoQ). This reporting practice reflects:

  • Analytical precision limits: Below certain thresholds, assays cannot reliably distinguish between slightly different low values
  • Clinical irrelevance: The distinction between 5 pg/mL and 35 pg/mL has no established clinical significance for diagnosis or prognosis

Clinical Significance of Very Low NT-proBNP

Rule-Out Performance

NT-proBNP values <100 pg/mL effectively exclude heart failure and ventricular dysfunction. The guideline-recommended rule-out threshold is 300 pg/mL for acute heart failure 2, but even the lower threshold of <100 pg/mL demonstrates:

  • Negative likelihood ratio of 0.28 for ventricular dysfunction 3
  • Reduces post-test probability of ventricular dysfunction from 18% to 6% 3
  • Sensitivity approaching 100% for excluding acute heart failure 4

Reference Range Context

In healthy populations without cardiovascular disease 5:

  • Males <30 years: median 21 pg/mL (97.5th percentile: 104 pg/mL)
  • Females <30 years: median 51 pg/mL (97.5th percentile: 196 pg/mL)
  • Age-specific 97.5th percentile URLs: <50 years = 162 ng/L; 50-75 years = 311 ng/L 1

A value <36 pg/mL falls well within normal reference ranges for all age groups and both sexes, indicating no detectable cardiac stress or ventricular dysfunction.

Does the Distinction Between Near-Zero and Near-35 pg/mL Matter?

No, this distinction provides no additional clinical information. Here's why:

Lack of Prognostic Differentiation

  • The entire range below 100 pg/mL functions as a single "rule-out" category
  • No studies demonstrate differential outcomes between values of 5 pg/mL versus 35 pg/mL
  • Both values indicate absence of significant cardiac pathology

Analytical Considerations

  • Assay imprecision at very low concentrations makes precise quantification unreliable
  • Biological variation at these levels exceeds the difference between near-zero and near-35 values
  • The clinical decision point (rule-out threshold) is far above this range at 100-300 pg/mL

Clinical Context

Even in patients with confirmed heart failure and preserved ejection fraction, those with NT-proBNP <125 pg/mL (which includes your entire <36 range) represent a distinct low-risk phenotype 6:

  • 77% lower risk of cardiovascular death or HF hospitalization (adjusted HR: 0.35)
  • Better cardiac function and fewer comorbidities
  • Similar symptom burden despite better prognosis

Practical Clinical Interpretation

When you see NT-proBNP <36 pg/mL:

  1. Heart failure is effectively ruled out - proceed with alternative diagnostic considerations
  2. Ventricular dysfunction is highly unlikely - echocardiography not urgently needed for this indication
  3. The exact value within this range is clinically meaningless - do not attempt to interpret differences between 10 vs 30 pg/mL
  4. Consider alternative diagnoses for the patient's symptoms (pulmonary disease, deconditioning, anxiety, etc.)

Important Caveats

When Low NT-proBNP May Be Misleading

  • Obesity: Significantly lowers NT-proBNP levels independent of cardiac status 2, 6
  • Flash pulmonary edema: Rapid-onset symptoms may not allow time for NT-proBNP elevation
  • Constrictive pericarditis or restrictive cardiomyopathy: May present with heart failure symptoms but lower NT-proBNP

Clinical Scenarios Where <36 pg/mL Is Common

  • Young, healthy individuals (especially males <30 years)
  • Patients with excellent cardiovascular health
  • Post-cardiac rehabilitation patients with good recovery 7

Bottom line: Report values <36 pg/mL as simply "very low" or "undetectable" in clinical documentation, as the specific number within this range carries no diagnostic or prognostic weight.

References

Related Questions

What factors elevate NT‑proBNP levels?
What does an NT‑proBNP level of 3302 pg/mL indicate?
In an adult with mild bilateral ankle edema and low pre‑test probability for heart failure who has repeatedly low B‑type natriuretic peptide (BNP) results, is the N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) also likely to be low?
In a 72‑year‑old non‑obese male with a low N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level and an E/A ratio of 0.69, what conclusions can be drawn about his diastolic function, and should he be evaluated for restrictive cardiomyopathy or constrictive pericarditis?
What is the interpretation and recommended management of a patient with BNP (B-type natriuretic peptide) 111 pg/mL, Hgb (hemoglobin) 11.5 g/dL, MCHC (mean corpuscular hemoglobin concentration) 29.1 g/dL, ANC (absolute neutrophil count) 6.73 ×10⁹/L, BUN (blood urea nitrogen) 27 mg/dL, calcium 8.3 mg/dL, AST (aspartate aminotransferase) 11 U/L, total protein 5.8 g/dL, and a BUN/creatinine ratio of 54?
In a 62-year-old female with acute decompensated heart failure on carvedilol, lisinopril, and intravenous furosemide who has refractory hypokalemia and a serum magnesium of 1.2 mg/dL, what is the next best step to prevent further hypokalemia?
What is the recommended treatment plan for gastrointestinal manifestations such as constipation, dysmotility, reflux, and small‑intestinal bacterial overgrowth in patients with Ehlers‑Danlos syndrome?
When should women have yearly mammograms?
What is the appropriate starting dose, titration schedule, and safety considerations for amitriptyline in treating gastrointestinal pain such as functional dyspepsia or IBS?
When should a 58-year-old woman undergo cervical cancer screening with Pap smear (and HPV testing)?
What is the prognosis for a 74‑year‑old patient with stage IV colon cancer with liver and bone metastases and a colon mass causing partial obstruction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question